Consistently, data from expression profiling by high-throughput sequencing suggested that FOXA2 mRNA was significantly lower in tumor samples compared with paired noncancerous tissue (GSE119336, Provided by Zhou G, Cao P and Li Y). This evidence concerns the gene FOXA2 and neoplasm.